TOR complex 2 is needed for cell cycle progression and anchorage-independent growth of MCF7 and PC3 tumor cells
2008
The Role of TOR Complex 2 in Tumor Cell Growth
publication
Evidence: moderate
Author Information
Author(s): Hietakangas Ville, Cohen Stephen M
Primary Institution: Temasek Life Sciences Laboratory
Hypothesis
Does TOR complex 2 activity influence the proliferation of tumor cells?
Conclusion
Inhibition of TORC2 activity can effectively reduce tumor cell proliferation and growth.
Supporting Evidence
- Inhibition of TORC2 reduced proliferation in both MCF7 and PC3 cells.
- Rictor depletion led to accumulation of cells in G1 phase of the cell cycle.
- Downregulation of Cyclin D1 was observed following Rictor knockdown.
Takeaway
This study found that blocking a specific protein complex in cancer cells can stop them from growing and spreading.
Methodology
The study used RNAi to knock down Rictor, a component of TORC2, in MCF7 and PC3 cells to assess its role in cell proliferation and growth.
Limitations
The study primarily focused on two cell lines, which may limit the generalizability of the findings.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website